Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$282.62
-1.1%
$267.12
$195.90
▼
$290.25
$682.52B0.227.47 million shs7.94 million shs
Morgan Stanley stock logo
MS
Morgan Stanley
$185.60
-2.7%
$192.10
$152.80
▼
$232.25
$295.68B1.236.40 million shs5.68 million shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-1.10%+0.27%+10.60%+4.27%+44.19%
Morgan Stanley stock logo
MS
Morgan Stanley
-2.61%-0.82%+2.69%-14.67%+13.34%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$282.62
-1.1%
$267.12
$195.90
▼
$290.25
$682.52B0.227.47 million shs7.94 million shs
Morgan Stanley stock logo
MS
Morgan Stanley
$185.60
-2.7%
$192.10
$152.80
▼
$232.25
$295.68B1.236.40 million shs5.68 million shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-1.10%+0.27%+10.60%+4.27%+44.19%
Morgan Stanley stock logo
MS
Morgan Stanley
-2.61%-0.82%+2.69%-14.67%+13.34%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.73
Moderate Buy$275.92-2.37% Downside
Morgan Stanley stock logo
MS
Morgan Stanley
2.50
Moderate Buy$214.8115.74% Upside

Current Analyst Ratings Breakdown

Latest JNJ and MS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/3/2026
Morgan Stanley stock logo
MS
Morgan Stanley
Reiterated RatingBuy (B)
11/2/2026
Morgan Stanley stock logo
MS
Morgan Stanley
Boost Price TargetBuy$236.00 ➝ $240.00
10/23/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
DowngradeBuy (B+) ➝ Buy (B-)
10/21/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
DowngradeBuy ➝ Hold
10/21/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
DowngradeBuy ➝ Hold
10/20/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Set Price Target$300.00
10/20/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Reiterated RatingBuy
10/19/2026
Morgan Stanley stock logo
MS
Morgan Stanley
Lower Price TargetOutperform$215.00 ➝ $210.00
10/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetOverweight$275.00 ➝ $287.00
10/16/2026
Morgan Stanley stock logo
MS
Morgan Stanley
Boost Price TargetNeutral$195.00 ➝ $198.00
10/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Set Price Target$270.00
(Data available from 11/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$94.19B7.22$14.07 per share20.08$33.87 per share8.34
Morgan Stanley stock logo
MS
Morgan Stanley
$119.66B2.42$13.29 per share13.97$69.46 per share2.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$6.6042.8224.452.8016.20%31.64%13.04%1/26/2027 (Estimated)
Morgan Stanley stock logo
MS
Morgan Stanley
$16.86B$12.6014.7313.911.2615.63%19.26%1.28%1/14/2027 (Estimated)

Latest JNJ and MS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/14/2026Q3 2026
Morgan Stanley stock logo
MS
Morgan Stanley
$2.93$3.03+$0.10$3.03$19.93 billion$20.34 billion
10/13/2026Q3 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.53$2.59+$0.06$0.09$25.38 billion$25.40 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.361.90%+5.25%81.21%64 Years
Morgan Stanley stock logo
MS
Morgan Stanley
$4.602.48%+22.42%36.51%12 Years

Latest JNJ and MS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/13/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.342.15%11/24/202611/24/202612/8/2026
10/14/2026
Morgan Stanley stock logo
MS
Morgan Stanley
quarterly$1.152.49%10/30/202610/30/202611/13/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.44
1.02
0.74
Morgan Stanley stock logo
MS
Morgan Stanley
3.58
0.79
0.79

Institutional Ownership

CompanyInstitutional Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Morgan Stanley stock logo
MS
Morgan Stanley
84.19%

Insider Ownership

CompanyInsider Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Morgan Stanley stock logo
MS
Morgan Stanley
0.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.40 billionOptionable
Morgan Stanley stock logo
MS
Morgan Stanley
82,9921.56 billion1.56 billionOptionable

Recent News About These Companies

7 Major Banks Reveal XRP ETF Holdings in Latest SEC Filings
Morgan Stanley sets 8,700 S&P 500 target for 2027
What Is Morgan Stanley (MS) Really Gaining From Its AI IPO Role?
MAPLIGHT THERAPEUTICS ($MPLT) Releases Q3 2026 Earnings
$ACCV stock is down 15% today. Here's what we see in our data.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$282.62 -3.13 (-1.09%)
Closing price 11/16/2026 03:59 PM Eastern
Extended Trading
$282.60 -0.02 (-0.01%)
As of 04:42 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Morgan Stanley stock logo

Morgan Stanley NYSE:MS

$185.60 -5.05 (-2.65%)
Closing price 11/16/2026 03:59 PM Eastern
Extended Trading
$184.86 -0.74 (-0.40%)
As of 04:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments. The Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides equity and fixed income products comprising sales, financing, prime brokerage, and market-making services; foreign exchange and commodities; corporate and commercial real estate loans, commercial mortgage and secured lending facilities, and financing for sales and trading customers, and asset-backed and mortgage lending; and wealth management services, investment, and research services. The Wealth Management segment offers financial advisor-led brokerage, custody, administrative, and investment advisory services; self-directed brokerage services; financial and wealth planning services; workplace services, including stock plan administration; annuity and insurance products; securities-based lending, residential real estate loans, and other lending products; banking; and retirement plan services to individual investors and small to medium-sized businesses and institutions. The Investment Management segment provides equity, fixed income, alternatives and solutions, and liquidity and overlay services to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors, corporations, and individuals through institutional and intermediary channels. The company was founded in 1924 and is headquartered in New York, New York.